Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.

por Webb, M. S., Harasym, T. O., Masin, D., Bally, M. B., Mayer, L. D.
Publicado 1995

Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumours.

por Mayer, L. D., Masin, D., Nayar, R., Boman, N. L., Bally, M. B.
Publicado 1995